Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Friday, April 25 2014 4:53am ET - U.S. Markets open in 4 hours and 37 minutes.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > Merck & Co., Inc. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Merck & Co., Inc. Company Profile
Merck's medicine bag helps asthmatics breathe easier and allows hypertension patients to relax a little. In addition to blockbuster asthma treatment Singulair, the pharmaceutical company's top sellers include cardiovascular drugs ranging from hypertension fighters Cozaar and Hyzaar to cholesterol combatants Vytorin, Zetia, and Zocor. Merck makes drugs in a broad range of other therapeutic areas as well: Januvia is a therapy for type 2 diabetes, Fosamax fights osteoporosis, and Cosopt and Trusopt treat eye disease. In addition to pharmaceuticals, the company makes childhood and adult vaccines for such diseases as measles, mumps, hepatitis, and shingles. Merck has agreed to acquire Schering-Plough for $41 billion.
Headlines for Merck & Co., Inc.
Merck KGaA: Form 8 (DD) - AZ Electronic Materials S.A.
Marketwire - Thu 7:41 am ET
Will These 3 Dividend Stocks Impress Investors This Earnings Season?
at Motley Fool - Wed 6:34 pm ET
This company just had the best new drug launch of all-time
- Wed 4:52 pm ET
Gilead, Illumina Q1 Earnings Win Wall Street's Love
at Investor's Business Daily, Inc. - Wed 11:39 am ET
More Headlines...
More on Merck & Co., Inc.
Quote Msgs
Chart Insider
Profile Financials
Reports Analyst Ratings
Research    
SEC    
Contact Information
Address: 1 Merck Dr.
Whitehouse Station, NJ 08889-0100
Phone:908-423-1000
Fax:908-735-1253
Financial Highlights
Fiscal Year End:December
Revenue (2008):23850.30 M
Revenue Growth (1 yr):(-1.40%)
Employees (2008):55,200
Employee Growth (1 yr):(-7.70%)
Key People
Chairman, President, and CEO: Richard T. (Dick) Clark
EVP and CFO: Peter N. Kellogg
EVP Global Services and CIO: J. Chris Scalet
Industry Information
Sector: Healthcare
Industry: Drug Manufacturers - Major
Top Competitors
GlaxoSmithKline plc
Pfizer Inc.
Sanofi-Aventis
 


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?